Amalgamated Bank Vigil Neuroscience, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$2.68 - $3.63 $2,304 - $3,121
-860 Reduced 61.34%
542 $2,000
Q4 2023

Feb 06, 2024
SELL
$2.97 - $8.6 $478 - $1,384
-161 Reduced 10.3%
1,402 $5,000
Q2 2023

Aug 11, 2023
BUY
$8.11 - $10.54 $12,675 - $16,474
1,563 New
1,563 $14,000
Q2 2022

Aug 15, 2022
SELL
$2.23 - $7.81 $5,465 - $19,142
-2,451 Closed
0 $0
Q1 2022

Jun 30, 2022
BUY
$7.03 - $17.29 $17,230 - $42,377
2,451 New
2,451 $17,000

Others Institutions Holding VIGL

# of Institutions
53
Shares Held
28.2M
Call Options Held
0
Put Options Held
0
View Full List

About Vigil Neuroscience, Inc.

VIGL Quotes by TradingView
  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $62.2M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email